Gilad Mamlok
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gilad Mamlok
Gilad Mamlok is recorded as CFO at Protalix BioTherapeutics, Inc. (PLX). Protalix BioTherapeutics, Inc. reported in an 8-K filed July 21, 2025 that Gilad Mamlok was appointed Senior Vice President and Chief Financial Officer, effective August 24, 2025.
“On July 21, 2025, Protalix BioTherapeutics, Inc. (the "Company") announced the appointment of Gilad Mamlok to serve as the Company's new Senior Vice President and Chief Financial Officer, effective August 24, 2025, succeeding Eyal Rubin.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Protalix BioTherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dror Bashan CEO, Board Member
- Eliot Richard Forster Chairman
- Eliot Richard Forster, Ph.D. Chairman
- Aharon Schwartz Board Member
- Amos Bar Shalev Board Member
- Christian Elze Board Member
- Gwen A. Melincoff Board Member
- Pol F. Boudes Board Member
- Shmuel Ben Zvi, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.